JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M206015200 on December 17, 2002

J. Biol. Chem., Vol. 278, Issue 9, 7189-7198, February 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/9/7189    most recent
M206015200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammar, L.
Right arrow Articles by Cheng, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammar, L.
Right arrow Articles by Cheng, R. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Prefusion Rearrangements Resulting in Fusion Peptide Exposure in Semliki Forest Virus*

Lena HammarDagger §, Sevak MarkarianDagger , Lars HaagDagger , Hilkka Lankinen, Aimo Salmi||, and R. Holland ChengDagger

From the Dagger  Department of Biosciences, Karolinska Institute, Huddinge S-141 57, Sweden, the  Haartman Institute, Department of Virology, Helsinki F-00014, Finland, and the || Department of Virology, University of Turku, Turku F-20520, Finland

Semliki Forest virus (SFV), like many enveloped viruses, takes advantage of the low pH in the endosome to convert into a fusion-competent configuration and complete infection by fusion with the endosomal membrane. Unlike influenza virus, carrying an N-terminal fusion peptide, SFV represents a less-well understood fusion principle involving an endosequence fusion peptide. To explore the series of events leading to a fusogenic configuration of the SFV, we exposed the virus to successive acidification, mimicking endosomal conditions, and followed structural rearrangements at probed sensor surfaces. Thus revealed, the initial phase involves a transient appearance of a non-linear neutralizing antibody epitope in the fusion protein, E1. Concurrent with the disappearance of this epitope, a set of masked sequences in proteins E1 and E2 became exposed. When pH reached 6.0-5.9 the virion transformed into a configuration of enlarged diameter with the fusion peptide optimally exposed. Simultaneously, a partly hidden sequence close to the receptor binding site in E2 became fully uncovered. At this presumably fusogenic stage, maximally 80 fusion peptide-identifying antibody Fab fragments could be bound per virion, i.e. one ligand per three copies of the fusion protein. The phenomena observed are discussed in terms of alphavirus structure and reported functional domains.


* This work was supported by the Swedish Medical Research Council, the Swedish Foundation for Strategic Research, and the Karolinska Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 46-8-608-9130; Fax: 46-8-774-5538; E-mail: lena.hammar@biosci.ki.se.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S.-R. Wu, L. Haag, M. Sjoberg, H. Garoff, and L. Hammar
The Dynamic Envelope of a Fusion Class II Virus: E3 DOMAIN OF GLYCOPROTEIN E2 PRECURSOR IN SEMLIKI FOREST VIRUS PROVIDES A UNIQUE CONTACT WITH THE FUSION PROTEIN E1
J. Biol. Chem., September 26, 2008; 283(39): 26452 - 26460.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-R. Wu, L. Haag, L. Hammar, B. Wu, H. Garoff, L. Xing, K. Murata, and R. H. Cheng
The Dynamic Envelope of a Fusion Class II Virus: PREFUSION STAGES OF SEMLIKI FOREST VIRUS REVEALED BY ELECTRON CRYOMICROSCOPY
J. Biol. Chem., March 2, 2007; 282(9): 6752 - 6762.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B.-L. Waarts, J. M. Smit, O. J. C. Aneke, G. M. McInerney, P. Liljestrom, R. Bittman, and J. Wilschut
Reversible Acid-Induced Inactivation of the Membrane Fusion Protein of Semliki Forest Virus
J. Virol., June 15, 2005; 79(12): 7942 - 7948.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. L. Gibbons, A. Ahn, M. Liao, L. Hammar, R. H. Cheng, and M. Kielian
Multistep Regulation of Membrane Insertion of the Fusion Peptide of Semliki Forest Virus
J. Virol., April 1, 2004; 78(7): 3312 - 3318.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.